BBNX logo

Beta Bionics, Inc. (BBNX) EBITDA

annual EBITDA:

-$42.97M-$9.21M(-27.28%)
December 31, 2024

Summary

  • As of today (August 20, 2025), BBNX annual EBITDA is -$42.97 million, with the most recent change of -$9.21 million (-27.28%) on December 31, 2024.
  • During the last 3 years, BBNX annual EBITDA has risen by +$19.68 million (+31.42%).
  • BBNX annual EBITDA is now -27.28% below its all-time high of -$33.76 million, reached on December 31, 2023.

Performance

1-year change

-27.28%

3-year change

+31.42%

5-year change

+31.42%

15-year change

+31.42%

BBNX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

33.82%
BBNX annual EBITDA is higher than 33.82% of companies in Healthcare sector

Range

All-time high

-$33.76M

3-year low

-$62.65M

Earnings dates

Last annual earnings report date

Dec 31, 2024
BBNX previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
BBNX next annual earnings announcement has not yet been scheduled

OtherBBNXincome statement metrics

Annual revenue

$65.12M
BBNX annual revenue is $65.12 million

annual net income

-$54.76M
BBNX annual net profit is -$54.76 million

annual EBIT

-$45.25M
BBNX annual earnings before interest & taxes is -$45.25 million

Annual EPS

$0.00
BBNX annual earnings per share is $0.00

quarterly EBITDA:

-$19.22M-$1.18M(-6.55%)
June 30, 2025

Summary

  • As of today (August 20, 2025), BBNX quarterly EBITDA is -$19.22 million, with the most recent change of -$1.18 million (-6.55%) on June 30, 2025.
  • Over the past year, BBNX quarterly EBITDA has dropped by -$8.01 million (-71.48%).
  • BBNX quarterly EBITDA is now -165.64% below its all-time high of -$7.24 million, reached on September 30, 2023.

Performance

3-month change

-6.55%

1-year change

-71.48%

3-year change

-165.64%

5-year change

-165.64%

BBNX quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

23.45%
BBNX quarterly EBITDA is higher than 23.45% of companies in Healthcare sector

Range

All-time high

-$7.24M

3-year low

-$19.22M
BBNX quarterly EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
BBNX previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
BBNX next earnings announcement is scheduled for Oct 28, 2025

OtherBBNXincome statement metrics

Quarterly revenue

$23.24M
BBNX quarterly revenue is $23.24 million

quarterly net income

-$16.87M
BBNX quarterly net profit is -$16.87 million

quarterly EBIT

-$19.87M
BBNX quarterly earnings before interest & taxes is -$19.87 million

Quarterly EPS

-$0.39
BBNX quarterly earnings per share is -$0.39

TTM EBITDA:

-$60.13M-$8.01M(-15.37%)
June 30, 2025

Summary

  • As of today (August 20, 2025), BBNX TTM EBITDA is -$60.13 million, with the most recent change of -$8.01 million (-15.37%) on June 30, 2025.
  • Over the past year, BBNX TTM EBITDA has dropped by -$24.97 million (-71.03%).
  • BBNX TTM EBITDA is now -731.06% below its all-time high of -$7.24 million, reached on September 30, 2023.

Performance

3-month change

-15.37%

1-year change

-71.03%

3-year change

-731.06%

5-year change

-731.06%

BBNX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

26.77%
BBNX TTM EBITDA is higher than 26.77% of companies in Healthcare sector

Range

All-time high

-$7.24M

3-year low

-$60.13M
BBNX TTM EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
BBNX previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
BBNX next earnings announcement is scheduled for Oct 28, 2025

OtherBBNXincome statement metrics

TTM revenue

$78.02M
BBNX TTM revenue is $78.02 million

TTM net income

-$73.37M
BBNX TTM net profit is -$73.37 million

TTM EBIT

-$62.53M
BBNX TTM earnings before interest & taxes is -$62.53 million

TTM EPS

-$1.32
BBNX TTM earnings per share is -$1.32

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$42.97M
BBNX annual EBITDA is -$42.97 million

annual net income

-$54.76M
BBNX annual net profit is -$54.76 million

annual interest expense

$0.00
BBNX annual interest expense is $0.00

annual income tax

$0.00
BBNX annual income tax is $0.00

annual D&A

$2.28M
BBNX annual depreciation & amortization is $2.28 million

BBNX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.3%-71.5%-71.0%
3 y3 years+31.4%-165.6%-731.1%
5 y5 years+31.4%-165.6%-731.1%

BBNX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-27.3%+31.4%-165.6%at low-731.1%at low
5 y5-year-27.3%+31.4%-165.6%at low-731.1%at low
alltimeall time-27.3%+31.4%-165.6%at low-731.1%at low

BBNX EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$19.22M(+6.5%)
-$60.13M(+15.4%)
Mar 2025
-
-$18.04M(+44.2%)
-$52.12M(+21.3%)
Dec 2024
-$42.97M
-$12.51M(+20.7%)
-$42.97M(+12.2%)
Sep 2024
-
-$10.36M(-7.5%)
-$38.28M(+8.9%)
DateAnnualQuarterlyTTM
Jun 2024
-
-$11.21M(+26.1%)
-$35.16M(+46.8%)
Mar 2024
-
-$8.89M(+13.6%)
-$23.95M(+59.0%)
Dec 2023
-$33.76M(-46.1%)
-$7.82M(+8.1%)
-$15.06M(+108.1%)
Sep 2023
-
-$7.24M
-$7.24M
Dec 2022
-$62.65M
-
-

FAQ

  • What is Beta Bionics, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. annual EBITDA year-on-year change?
  • What is Beta Bionics, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. quarterly EBITDA year-on-year change?
  • What is Beta Bionics, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. TTM EBITDA year-on-year change?

What is Beta Bionics, Inc. annual EBITDA?

The current annual EBITDA of BBNX is -$42.97M

What is the all time high annual EBITDA for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high annual EBITDA is -$33.76M

What is Beta Bionics, Inc. annual EBITDA year-on-year change?

Over the past year, BBNX annual EBITDA has changed by -$9.21M (-27.28%)

What is Beta Bionics, Inc. quarterly EBITDA?

The current quarterly EBITDA of BBNX is -$19.22M

What is the all time high quarterly EBITDA for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high quarterly EBITDA is -$7.24M

What is Beta Bionics, Inc. quarterly EBITDA year-on-year change?

Over the past year, BBNX quarterly EBITDA has changed by -$8.01M (-71.48%)

What is Beta Bionics, Inc. TTM EBITDA?

The current TTM EBITDA of BBNX is -$60.13M

What is the all time high TTM EBITDA for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high TTM EBITDA is -$7.24M

What is Beta Bionics, Inc. TTM EBITDA year-on-year change?

Over the past year, BBNX TTM EBITDA has changed by -$24.97M (-71.03%)
On this page